Alcon Inc (ALC)
85.53
+0.03
(+0.04%)
USD |
NYSE |
Nov 21, 16:00
85.53
0.00 (0.00%)
After-Hours: 20:00
Alcon Market Cap: 42.30B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 42.29B |
| November 19, 2024 | 42.25B |
| November 18, 2024 | 42.44B |
| November 15, 2024 | 42.11B |
| November 14, 2024 | 42.13B |
| November 13, 2024 | 43.27B |
| November 12, 2024 | 42.98B |
| November 11, 2024 | 45.64B |
| November 08, 2024 | 45.80B |
| November 07, 2024 | 45.80B |
| November 06, 2024 | 45.24B |
| November 05, 2024 | 45.72B |
| November 04, 2024 | 45.59B |
| November 01, 2024 | 45.40B |
| October 31, 2024 | 45.48B |
| October 30, 2024 | 46.13B |
| October 29, 2024 | 46.74B |
| October 28, 2024 | 46.92B |
| October 25, 2024 | 46.62B |
| October 24, 2024 | 46.69B |
| October 23, 2024 | 46.74B |
| October 22, 2024 | 46.81B |
| October 21, 2024 | 46.66B |
| October 18, 2024 | 47.06B |
| October 17, 2024 | 46.75B |
| Date | Value |
|---|---|
| October 16, 2024 | 47.13B |
| October 15, 2024 | 47.78B |
| October 14, 2024 | 48.08B |
| October 11, 2024 | 47.82B |
| October 10, 2024 | 47.64B |
| October 09, 2024 | 47.70B |
| October 08, 2024 | 47.44B |
| October 07, 2024 | 47.20B |
| October 04, 2024 | 48.11B |
| October 03, 2024 | 48.53B |
| October 02, 2024 | 49.03B |
| October 01, 2024 | 49.02B |
| September 30, 2024 | 49.49B |
| September 27, 2024 | 49.15B |
| September 26, 2024 | 48.87B |
| September 25, 2024 | 48.72B |
| September 24, 2024 | 48.52B |
| September 23, 2024 | 48.32B |
| September 20, 2024 | 48.08B |
| September 19, 2024 | 48.50B |
| September 18, 2024 | 47.67B |
| September 17, 2024 | 47.92B |
| September 16, 2024 | 48.64B |
| September 13, 2024 | 48.58B |
| September 12, 2024 | 49.70B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
19.46B
Minimum
Mar 23 2020
49.70B
Maximum
Sep 12 2024
35.88B
Average
35.85B
Median
Market Cap Benchmarks
| AC Immune SA | 325.03M |
| CRISPR Therapeutics AG | 3.952B |
| Addex Therapeutics Ltd | 8.795M |
| NLS Pharmaceutics Ltd | 12.93M |
| Molecular Partners AG | 196.71M |
Market Cap Related Metrics
| PE Ratio | 36.55 |
| PS Ratio | 4.356 |
| PEG Ratio | 0.2285 |
| Price to Book Value | 2.020 |
| Price | 85.53 |
| Earnings Yield | 2.74% |
| PEGY Ratio | 0.2280 |
| Operating PE Ratio | 34.68 |
| Normalized PE Ratio | 36.55 |